Itolizumab

3 posts

India's missing research papers

2 min read
Science Bharat Biotech Biocon Covaxin COVID-19 COVID-19 epidemic COVID-19 pandemic ELISA test kit favipiravir hydroxychloroquine Indian Council of Medical Research Itolizumab novel coronavirus peer review preprint papers remdesivir science academies science by press release seroprevalence survey Tata Institute of Fundamental Research tocilizumab Zydus Cadila

If you're looking for a quantification (although you shouldn't) of the extent to which science is being conducted by press releases in India at the moment, consider the following list of studi…

The matter of a journal's reputation

5 min read
Analysis Science Biocon Björn Brembs COVID-19 cytokine release syndrome Dinesh Thakur Drug Controller General of India Itolizumab Jammi Nagaraj Rao journal impact factor Kiran Mazumdar-Shaw Newslaundry phase II clinical trials phase III clinical trials prestige journals prestigious journals reputed journals Seema Ahuja Sundar Ramanan The Telegraph

Apparently (and surprisingly) The Telegraph didn’t allow Dinesh Thakur to respond to an article by Biocon employee Sundar Ramanan, in which Ramanan deems Thakur’s article about the claims to efficacy…